GLAONS Survey of Oncology Nurses Reveals Knowledge Gap Regarding Genetic Evaluation and LGBTQIA+ Cancer Care

In September 2022, i3 Health conducted a survey of 157 oncology nurses at the Greater Los Angeles Oncology Nursing Society (GLAONS) 6th Annual Oncology Care Summit to assess nurses' familiarity with and desire to understand genetic evaluation and counseling and LGBTQIA+ cancer care. Through genetic evaluation and counseling care, patients can better understand their genome and how their DNA might be able to warn them, and even their family, about their risks of developing certain cancers and dis...

Continue reading

Survey of Oncology Nurses Reveals Need for Knowledge Regarding Genetic Evaluation and LGBTQIA+ Cancer Care

In May of 2022, i3 Health conducted a survey of 230 oncology nurses at the Oncology Nursing Society (ONS) 47th Annual Congress in Anaheim, California, to assess nurses' familiarity and desire to understand genetic evaluation and counseling and LGBTQIA+ cancer care. Genetic evaluation and counseling are ways for patients to better understand their genome and how their DNA might be able to warn them, and even their family, about their risks to certain cancers and diseases. These types of procedure...

Continue reading

Improving Patient Experiences in Multiple Myeloma With Tiffany Richards, PhD, ANP-BC

At the Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit in Los Angeles, California, Oncology Data Advisor spoke with Tiffany Richards, PhD, ANP-BC, Advanced Practice Nurse at MD Anderson Cancer Center, about strategies for optimizing patient experiences during multiple myeloma treatment. Dr. Richards discusses the challenges of treating patients with multiple myeloma, particularly during the COVID-19 pandemic, and shares strategies for promoting adherence and optimizing...

Continue reading

i3 Health Presents Oncology Nursing Showdown: Non-Hodgkin Lymphoma Edition at Oncology Nursing Society Congress

i3 Health's study focusing on the effectiveness of a nursing continuing professional development (NCPD)–approved activity to improve clinicians' knowledge of the individualized treatment of patients with non-Hodgkin lymphoma (NHL) has been published as a 47th Annual Oncology Nursing Society (ONS) Congress online abstract. The abstract, authored by Elizabeth Heller, PhD; Keira Smith, BA; Kristin Wright, PharmD; and Sarah Williams, MAT, of i3 Health, and Maria Badillo, MSN, RN, OCN®, CCRP, Researc...

Continue reading

Enhancing Nurse Well-Being by Building Resiliency to Trauma With Bina Parekh, PhD

At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Bina Parekh, PhD, explained the concept of vicarious trauma and empowered nurses with positive personal growth strategies to deal with challenges, fears, and trauma that stem from dealing with patients with cancer. In this interview with Oncology Data Advisor, Dr. Parekh discusses the concept of vicarious trauma and how nurses, programmed to care for others, are often affected. She shares advice for nurses on how to ad...

Continue reading

Becoming Involved in Oncology Cooperative Groups With Deborah Watkins Bruner, RN, PhD, FAAN

At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Deborah Watkins Bruner, Senior Vice President of Research at Emory University, gave a presentation to shed light on the value of oncology cooperative groups. In this interview, Dr. Watkins Bruner provides additional insight into the opportunities surrounding cooperative groups and shares resources for members of the nursing community who are interested in becoming involved. Oncology Data Advisor: Thank you for joining ...

Continue reading

Improving Safety and Efficiency of Oral Chemotherapy Administration With Cynthia Huff, DNP, RN

At the recent 47th Oncology Nursing Society (ONS) Congress in Anaheim, California, Cynthia Huff, DNP, RN, MSN, OCN®, CRNI, CNL®, Manager of the Ambulatory Infusion Center at Long Beach Medical Center, presented two posters about the importance of safe oral chemotherapy administration and the need to ensure proper lab monitoring and follow-up for patients receiving chemotherapy. Afterwards, she spoke with Oncology Data Advisor to further expound on her work in these areas and her passion for guar...

Continue reading

Raising Awareness About Medical Aid in Dying With Janet Rowe and Lisa Vigil Schattinger

At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Janet Rowe, RN, and Lisa Vigil Schattinger, MSN, RN, gave a presentation about medical aid in dying and the nurse's role in supporting their terminally ill patients' rights to autonomous decision-making. In this interview with Oncology Data Advisor, Ms. Rowe and Ms. Vigil Schattinger discuss their own experiences with medical aid in dying, explain their work to spread awareness and provide education to the community, and share additional advice for nurses on how to engage patients and families in meaningful conversations about this important issue.  

Continue reading

Reigniting the Passion as an Oncology Nurse With Nicola Stewart, MHL, BSN, RN-BC, OCN®

At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Nicola Stewart, Oncology Nurse Navigator at Methodist Healthcare/Sarah Cannon Cancer Institute, gave a presentation about boosting nursing morale by investing in the individual person and building the team. In this interview with Oncology Data Advisor, she shares additional advice for reigniting the passion as an oncology nurse, including the importance of remembering your "why."  

Continue reading

A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD: May 2022

From my perch atop the masthead at Oncology Data Advisor, I am awed by the dozens of oncology professionals who give freely of their time and expertise to inform our readership of the latest in their respective areas. Their efforts are what make ODA a premier online resource for all things in this ever-evolving field. My heartfelt thanks go to these wonderful colleagues without whom we would cease to be a publication. In this month's Editor's Letter, I would like to highlight a few of the outsta...

Continue reading

Copyright © Oncology Data Advisor. All rights reserved.